Integrative pathway dissection of molecular mechanisms of moxLDL-induced vascular smooth muscle phenotype transformation

Abstract

BackgroundAtherosclerosis (AT) is a chronic inflammatory disease characterized by the accumulation of inflammatory cells, lipoproteins and fibrous tissue in the walls of arteries. AT is the primary cause of heart attacks and stroke and is the leading cause of death in Western countries. To date, the pathogenesis of AT is not well-defined. Studies have shown that the dedifferentiation of contractile and quiescent vascular smooth muscle cells (SMC) to the proliferative, migratory and synthetic phenotype in the intima is pivotal for the onset and progression of AT. To further delineate the mechanisms underlying the pathogenesis of AT, we analyzed the early molecular pathways and networks involved in the SMC phenotype transformation.MethodsQuiescent human coronary artery SMCs were treated with minimally-oxidized LDL (moxLDL), for 3 hours and 21 hours, respectively. Transcriptomic data was generated for both time-points using microarrays and was subjected to pathway analysis using Gene Set Enrichment Analysis, GeneMANIA and Ingenuity software tools. Gene expression heat maps and pathways enriched in differentially expressed genes were compared to identify functional biological themes to elucidate early and late molecular mechanisms of moxLDL-induced SMC dedifferentiation.ResultsDifferentially expressed genes were found to be enriched in cholesterol biosynthesis, inflammatory cytokines, chemokines, growth factors, cell cycle control and myogenic contraction themes. These pathways are consistent with inflammatory responses, cell proliferation, migration and ECM production, which are characteristic of SMC dedifferentiation. Furthermore, up-regulation of cholesterol synthesis and dysregulation of cholesterol metabolism was observed in moxLDL-induced SMC. These observations are consistent with the accumulation of cholesterol and oxidized cholesterol esters, which induce proinflammatory reactions during atherogenesis. Our data implicate for the first time IL12, IFN-α, HGF, CSF3, and VEGF signaling in SMC phenotype transformation. GPCR signaling, HBP1 (repressor of cyclin D1 and CDKN1B), and ID2 and ZEB1 transcriptional regulators were also found to have important roles in SMC dedifferentiation. Several microRNAs were observed to regulate the SMC phenotype transformation via an interaction with IFN-γ pathway. Also, several “nexus” genes in complex networks, including components of the multi-subunit enzyme complex involved in the terminal stages of cholesterol synthesis, microRNAs (miR-203, miR-511, miR-590-3p, miR-346*/miR- 1207-5p/miR-4763-3p), GPCR proteins (GPR1, GPR64, GPRC5A, GPR171, GPR176, GPR32, GPR25, GPR124) and signal transduction pathways, were found to be regulated.ConclusionsThe systems biology analysis of the in vitro model of moxLDL-induced VSMC phenotype transformation was associated with the regulation of several genes not previously implicated in SMC phenotype transformation. The identification of these potential candidate genes enable hypothesis generation and in vivo functional experimentation (such as g...

Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin‐1

“…Protein–protein interaction analysis was performed via STRING tool (http://string-db.org/) (Jensen et al., 2009). Pathway analysis was performed with Ingenuity Pathway analysis (Ingenuity ® Systems; IPA) software (http://www.ingenuity.com/), as previously described (Karagiannis et al., 2013; Prassas et al., 2011). For details, refer to Supplementary Materials and Methods.…”

Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology

“…For example, inflammation has been implicated as one of the initiating factors of neointimal hyperplasia, whether in the setting of atherosclerosis or neointimal hyperplasia. IL12A, encoding interleukin-12, is one of the most highly up-regulated genes for TSP-1 (10-fold) and TSP-5 (14-fold), and has been recently implicated in the phenotypic transformation of VSMCs [17]. As for growth factors, PDGFB, encoding PDGFβ, was expressed at the 3 and 6 hour time points for all three TSPs and at 24 hours for TSP-2, however undetectable in the SFM-only samples.…”

Galectin-3 induces the phenotype transformation of human vascular smooth muscle cells via the canonical Wnt signaling

“…Atherosclerosis is the primary cause of heart disease and stroke, and it is also one of the main causes of death and disability around the world (1,2). The phenotype transformation of vascular smooth muscle cell (VSMC) plays an important role in the pathology process of atherosclerosis.…”